This blog site is part of the Month of CIRM series on the Stem Cellar.
The questions we get most regularly from members of the public are about our clinical trials. Typically, people want to know what stem cell-based trials our Agency is funding or whether weâre funding trials for specific diseases or disorders that either they or their loved one are afflicted with.
During these conversations, we refer people to our websiteâs clinical trials page, which lists all of the trials CIRM has funded since our Agency was established in 2004. This page previously featured a simple table (see image below) that listed basic information about CIRM-funded trials including links to CIRM grants and to trial details on clinicaltrials. gov. This dining table was not the most exciting way to feature our clinical portfolio, but it did what it needed to do at that time.
CIRMâs former clinical trials dining table.
Hereâs where I reference Bob Dylanâs famous lyric, âthe times, they are a-changingâ. CIRMâs clinical portfolio has rapidly expanded from 17 funded trials to 40 since the launch of our Strategic Plan in 2016. Thatâs 23 new trials in under two years. The number of CIRM-funded trials will continue to climb steadily every year as we strive to reach our Strategic Planâs goal of funding yet another 27 new trials by 2020.
This rapid expansion in our clinical portfolio is very exciting since it brings us closer to achieving our mission of accelerating stem cell treatments to patients with unmet medical needs. It also means that itâs finally time to retire our old clinical trials table and replace it with something that does our expanding portfolio justice, and makes it easier for anyone who is interested to understand about the trials weâre funding.
That something is already here and itâs called the Clinical Dashboard. Itâs an interactive Dashboard that allows users to filter through CIRMâs clinical portfolio by clicking on tabs for major disease indications. Users may also sort trials by disease area, investigator, organization, and the phase or status of the trial.
The CIRM Clinical Dashboard premiered in September, 2017.
The Dashboard is a snapshot of the fundamental information a scientist, patient, or member of the public needs to know about our trials. Users who want to learn more about confirmed trial, beyond whatâs listed in the Dashboard, can click on the arrow in the âDetailâ column. This takes users to a detailed trials page featuring information about the treatment being tested, the CIRM clinical award that funded the trial, information regarding trialâs design, goals and patient enrollment status, and any recently published news about the trial.
The details page also has resources designed for patients including a link for patients to contact the trial sponsor to ask about trial eligibility and enrollment and links to general information regarding stem cell trials on the CIRM website and from other organizations.
You can learn more about specific CIRM-funded trials by clicking the âDetailâ icon on the Dashboard.
With our new Clinical Dashboard, we hope to raise the visibility of CIRMâs expanding clinical trial portfolio and to provide an all-in-one resource that’s useful for multiple audiences.
Dr. Maria Millan, President and CEO of CIRM, concluded:
âCIRM is really a global leader in funding top quality stem cell trials for patients. We created the Clinical Dashboard for our website so that people can simply access important information about CIRM-funded trials and the promising trea